SCHEMBL7963049

SCHEMBL7963049

NC(=O)c1cccc2c1c1c(OCC(=O)O)ccc(Cl)c1n2Cc1cccc(OC(F)F)c1

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 19/20 0.49
PLA2G1B P04054 5/20 0.46
PLA2G10 O15496 3/20 0.44
PLA2G2E Q9NZK7 3/20 0.44
PLA2G5 P39877 2/20 0.44
PLA2G2F Q9BZM2 2/20 0.43
PLA2G2D Q9UNK4 2/20 0.43
PLA2G6 O60733 1/20 0.43
PLA2G2C Q5R387 1/20 0.43
PLA2G12B Q9BX93 1/20 0.43
PLA2G12A Q9BZM1 1/20 0.43
PLA2G3 Q9NZ20 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7963046 0.89 ROCK2 (0.37) PLA2G2APLA2G1B
SCHEMBL819918 0.88 PLA2G2A (0.55) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5
SCHEMBL29862557 0.88 PLA2G2A (0.55) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5
SCHEMBL7963042 0.87 PLA2G2A (0.37) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5
SCHEMBL7966274 0.81 PLA2G2A (0.44) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5
SCHEMBL27505221 0.80 ADRA1D (0.36) PLA2G2APLA2G1BPLA2G10
SCHEMBL6695147 0.80 PLA2G2A (0.58) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5
SCHEMBL818554 0.80 PLA2G2A (0.54) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5
SCHEMBL30410237 0.79 PLA2G2A (0.50) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5
SCHEMBL818102 0.79 PLA2G2A (0.50) PLA2G2APLA2G1BPLA2G10PLA2G2EPLA2G5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed